|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01789 AK MEDICAL
Nominal 
6.470 -0.120 (-1.821%) | 2023/06 - Interim RMB(¥) | %Chg (Interim to Interim) | 2022/12 RMB(¥) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | ||
| Turnover | 648,686,000 | 22.115% | 1,052,047,000 | 761,441,000 | 1,035,386,000 | 926,705,000 | |
| Cost of Sales | (247,121,000) | 28.257% | (415,612,000) | (262,252,000) | (320,854,000) | (283,454,000) | |
| Gross Profit | 401,565,000 | 18.618% | 636,435,000 | 499,189,000 | 714,532,000 | 643,251,000 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (18,360,000) | -- | (8,848,000) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 157,988,000 | 5.710% | 240,290,000 | 108,559,000 | 376,607,000 | 321,402,000 | |
| Taxation | (25,414,000) | 8.509% | (35,518,000) | (15,940,000) | (62,600,000) | (54,410,000) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 132,574,000 | 5.190% | 204,772,000 | 92,619,000 | 314,007,000 | 266,992,000 | |
| Net Finance Costs / (Income) | (14,278,000) | -2.279% | (20,307,000) | (9,123,000) | (7,681,000) | (5,881,000) | |
| Depreciation & Amortisation | -- | -- | 80,401,000 | 74,158,000 | 60,521,000 | 32,157,000 | |
| Directors' Emoluments | -- | -- | -- | 3,746,000 | 3,150,000 | 6,045,000 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 12.000 | -- | 18.000 | 8.000 | 28.000 | 26.000 |
| DPS (cts) | 0.000 | -- | 5.226 | 2.037 | 3.350 | 6.766 |
| Dividend Payout Ratio (%) | -- | -- | 29.036% | 25.460% | 11.964% | 26.024% |
| Cash flow per share ($) | -- | -- | -- | 0.159 | 0.186 | 0.139 |
| NBV per share ($) | 2.092 | -- | 2.011 | 1.821 | 1.831 | 1.060 |
| Remarks: | Real time quote last updated: 21/09/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 132,574,000 |
| %Change | 5.190% |
| EPS / (LPS) | RMB 0.120 |
| NBV Per Share (¥) | RMB 2.092 |